Company Search:
Advanced Search
Sponsored Links
Antibe Therapeutics Inc Company Snapshot
Antibe Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Antibe Therapeutics Inc with three other miscellaneous service companies in North America: Pharmaxis Ltd of the United States (2019 sales of $8.97 million of which 48% was New Drug Development), Aytu Bioscience Inc of the United States ($7.32 million of which 100% was Identifying, acquiring, and commercializ), and Immutep Ltd which is also based in the United States ($4.31 million of which 93% was Cancer Immunotherapy).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Antibe Therapeutics Inc
  Stock Performance Chart for Antibe Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .43
(Figures in Canadian Dollars)
1 Week 11.8%   13 Weeks 1.2%  
4 Weeks 4.9%   52 Weeks 73.5%  
Antibe Therapeutics Inc Key Data:
  Ticker: ATE Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 9,538,942
(Year Ending Jan 2020).
Employees: 3
  Currency: Canadian Dollars Market Cap: 116,522,534
  Fiscal Yr Ends: March Shares Outstanding: 274,170,668
  Share Type: Common Closely Held Shares: 8,666,195
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.